Cargando…
What is the effect of benzodiazepines on deep brain activity? A study in pediatric patients with dystonia
INTRODUCTION: Benzodiazepines (BDZs) are commonly used to treat the symptoms of movement disorders; however, deep brain stimulation (DBS) has become a popular treatment for these disorders. Previous studies have investigated the effects of BDZ on cortical activity, no data are currently available on...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457157/ https://www.ncbi.nlm.nih.gov/pubmed/37638186 http://dx.doi.org/10.3389/fneur.2023.1215572 |
_version_ | 1785096861414064128 |
---|---|
author | Hernandez-Martin, Estefania Vidmark, Jessica S. L. MacLean, Jennifer A. Sanger, Terence D. |
author_facet | Hernandez-Martin, Estefania Vidmark, Jessica S. L. MacLean, Jennifer A. Sanger, Terence D. |
author_sort | Hernandez-Martin, Estefania |
collection | PubMed |
description | INTRODUCTION: Benzodiazepines (BDZs) are commonly used to treat the symptoms of movement disorders; however, deep brain stimulation (DBS) has become a popular treatment for these disorders. Previous studies have investigated the effects of BDZ on cortical activity, no data are currently available on their effects on deep brain regions, nor on these regions’ responses to DBS. How the BDZ affects the thalamus and basal ganglia in dystonia patients remains unknown. METHODS: DBS recordings were performed in ventral oralis anterior/posterior (VoaVop), ventral intermediate (VIM) and ventral anterior (VA) thalamic subnuclei, as well as globus pallidus interna (GPi) and subthalamic nucleus (STN). Evoked potentials (EP) and frequency domain analysis were performed to determine the BDZ effect on neural activities compared to the control condition (off-BDZ). Three male pediatric patients with dystonia treated with BDZ and undergoing depth electrode evaluation for clinical targeting were recruited for the study. Stimulation was administered at 25 and 55 Hz frequencies and recordings were simultaneously gathered through pairs of externalized stereoelectroencephalography (sEEG) electrodes. EP amplitude and the effect of stimulation on the frequency spectrum of activity were compared at baseline and following clinical administration of BDZ. RESULTS: Frequency analysis showed consistent reductions in activity during BDZ treatment in all studied brain regions for all patients. Evoked potential (EP) analysis showed increased subthalamic nucleus (STN) EP amplitude and decreased ventral intermediate (VIM) and STN EP amplitude during BDZ treatment. INTERPRETATION: BDZs reduce thalamic and basal ganglia activity in multiple regions and alter the efficacy of transmission between these regions. While the mechanism is unknown our results confirm the known widespread effects of this class of medications and identify specific areas within the motor system that are directly affected. |
format | Online Article Text |
id | pubmed-10457157 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-104571572023-08-26 What is the effect of benzodiazepines on deep brain activity? A study in pediatric patients with dystonia Hernandez-Martin, Estefania Vidmark, Jessica S. L. MacLean, Jennifer A. Sanger, Terence D. Front Neurol Neurology INTRODUCTION: Benzodiazepines (BDZs) are commonly used to treat the symptoms of movement disorders; however, deep brain stimulation (DBS) has become a popular treatment for these disorders. Previous studies have investigated the effects of BDZ on cortical activity, no data are currently available on their effects on deep brain regions, nor on these regions’ responses to DBS. How the BDZ affects the thalamus and basal ganglia in dystonia patients remains unknown. METHODS: DBS recordings were performed in ventral oralis anterior/posterior (VoaVop), ventral intermediate (VIM) and ventral anterior (VA) thalamic subnuclei, as well as globus pallidus interna (GPi) and subthalamic nucleus (STN). Evoked potentials (EP) and frequency domain analysis were performed to determine the BDZ effect on neural activities compared to the control condition (off-BDZ). Three male pediatric patients with dystonia treated with BDZ and undergoing depth electrode evaluation for clinical targeting were recruited for the study. Stimulation was administered at 25 and 55 Hz frequencies and recordings were simultaneously gathered through pairs of externalized stereoelectroencephalography (sEEG) electrodes. EP amplitude and the effect of stimulation on the frequency spectrum of activity were compared at baseline and following clinical administration of BDZ. RESULTS: Frequency analysis showed consistent reductions in activity during BDZ treatment in all studied brain regions for all patients. Evoked potential (EP) analysis showed increased subthalamic nucleus (STN) EP amplitude and decreased ventral intermediate (VIM) and STN EP amplitude during BDZ treatment. INTERPRETATION: BDZs reduce thalamic and basal ganglia activity in multiple regions and alter the efficacy of transmission between these regions. While the mechanism is unknown our results confirm the known widespread effects of this class of medications and identify specific areas within the motor system that are directly affected. Frontiers Media S.A. 2023-08-11 /pmc/articles/PMC10457157/ /pubmed/37638186 http://dx.doi.org/10.3389/fneur.2023.1215572 Text en Copyright © 2023 Hernandez-Martin, Vidmark, MacLean and Sanger. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neurology Hernandez-Martin, Estefania Vidmark, Jessica S. L. MacLean, Jennifer A. Sanger, Terence D. What is the effect of benzodiazepines on deep brain activity? A study in pediatric patients with dystonia |
title | What is the effect of benzodiazepines on deep brain activity? A study in pediatric patients with dystonia |
title_full | What is the effect of benzodiazepines on deep brain activity? A study in pediatric patients with dystonia |
title_fullStr | What is the effect of benzodiazepines on deep brain activity? A study in pediatric patients with dystonia |
title_full_unstemmed | What is the effect of benzodiazepines on deep brain activity? A study in pediatric patients with dystonia |
title_short | What is the effect of benzodiazepines on deep brain activity? A study in pediatric patients with dystonia |
title_sort | what is the effect of benzodiazepines on deep brain activity? a study in pediatric patients with dystonia |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457157/ https://www.ncbi.nlm.nih.gov/pubmed/37638186 http://dx.doi.org/10.3389/fneur.2023.1215572 |
work_keys_str_mv | AT hernandezmartinestefania whatistheeffectofbenzodiazepinesondeepbrainactivityastudyinpediatricpatientswithdystonia AT vidmarkjessicasl whatistheeffectofbenzodiazepinesondeepbrainactivityastudyinpediatricpatientswithdystonia AT macleanjennifera whatistheeffectofbenzodiazepinesondeepbrainactivityastudyinpediatricpatientswithdystonia AT sangerterenced whatistheeffectofbenzodiazepinesondeepbrainactivityastudyinpediatricpatientswithdystonia |